Reverie Labs
@reverielabs
Followers
696
Following
54
Media
0
Statuses
41
Engineering next-generation kinase inhibitors with computation. https://t.co/Tz3njGiJTd
Joined January 2018
We are so excited to announce the acquisition of Reverie Labs' Platform by Ginkgo Bioworks: https://t.co/HUuZIPPO59
biopharma.ginkgo.bio
Today, we’re pleased to announce the acquisition of key assets of Reverie Labs, which built and used AI/ML tools to accelerate drug discovery. Ginkgo...
0
3
18
We are thrilled to share that @GuptaAnkitV, our Co-Founder and CTO will be speaking at the upcoming AWS Life Sciences Executive Symposium in Boston on May 15! https://t.co/XXzIwg4guc
pages.awscloud.com
Join us for this exclusive, executive event to learn how life sciences leaders are advancing innovations through robust data foundations and machine learning on the cloud. Hear real-world examples...
0
0
4
Valarie joins Reverie with more than a decade of experience, most recently at Yale Ventures and Nimbus Therapeutics, where she was involved in advancing clinical & early stage programs, including their AMPK and TYK2 programs. Welcome, Valarie, we're thrilled to have you on board!
0
1
1
I’m delighted to announce that we have hired Valarie Truax, Ph.D., M.B.A. as VP of Business Development and Corporate Strategy at @reverielabs!
1
2
12
Check out the fresh post on the @reverielabs blog from Stephen on our ML inference system!
We've got a new post on the Reverie Engineering Blog! Check out Stephen's work using asyncio to scale the ML inference workloads for our therapeutic programs at @reverielabs
https://t.co/k8ryfsH1ds
0
0
1
I’m excited to attend JPM next week! If you’re interested in hearing about some exciting recent updates to our programs, our ML and computational chemistry drug discovery platform, or our career opportunities (including a couple opportunities in BD!), please reach out.
0
2
19
We are very excited to announce that our co-founders @jonahkallenbach and @GuptaAnkitV have been named to the 2023 Forbes 30 under 30 list for Healthcare!
1
2
12
Want to create clean frontends for your Python apps with @vuejs? Check out how @reverielabs built a protein database interface with a single Vue component! https://t.co/kWoQOJfzB1
1
3
14
Reverie is hiring a Head of People! If recruiting and supporting an exceptional, diverse group of people at a rapidly growing therapeutics company sounds fun, my DMs are open :) https://t.co/QSaeDIMGLX
0
3
8
Another great blog post on the @reverielabs engineering blog, this time on using @streamlit for drug discovery from the mega-talented @jus10chavez !
Want to create web applications from your Python scripts? Check out how @reverielabs built a drug discovery app from a single script with @streamlit!
0
0
12
I wrote a blog post about UMAP and how we use it to understand chemical datasets for ML @reverielabs!! Check it out for the pretty plots, stay for the genuinely fun data analysis :) Comes with interactive @bokeh visualizations & @GoogleColab notebook: https://t.co/2RyD46ZlpF
3
24
105
🤯
Incredible new blog post from @ElanaPearl! If you like cheminformatics I guarantee the section on penimocycline will blow your mind:
0
0
0
Jam-packed new blog post (with code and illustrations!) from the brilliant @ElanaPearl on using UMAP to explore molecular ML datasets. https://t.co/E050Emqdk2
0
3
12
@reverielabs is hiring a Head of Biology!
Incredibly exciting opportunity to lead and build out Reverie's biology group. Please reach out if you're interested!
0
1
6
Great blog post from one of @reverielabs' extremely talented machine learning engineers on our system for managing structural data in kinase drug discovery:
1
5
27
Congratulations to the @reverielabs (YC W18) team! Reverie, a cancer therapeutics company driven by computation, raised a $25M Series A to reinvent one of the oldest cancer targets: https://t.co/zFTEef30Zz
endpoints.news
Jonah Kallenbach spent the summer before his senior year with Anton, the hulking fluorescent supercomputer housed in the midtown Manhattan offices of hedge fund D.E. Shaw. Armed with 512 processors...
0
14
51
Super impressed w/ @JonahCallinBack & @GuptaAnkitV for how they’re building @reverielabs. Heads-down focus on science, team & results ... + built *early* relationships with pharma & investors. Knew in advance what they had to prove and did it. More work to do, but well-earned 👏
Very excited to announce @reverielabs $25M Series A round, led by Ridgeback Capital! I'm in awe of our team and what they've accomplished so far. Now back to executing on our mission of bringing life saving medicines to patients, ASAP! https://t.co/IvoKN7rmSU
0
3
8
A major milestone at @reverielabs this morning! Proud of the whole team for pushing through a tough pandemic period to reach this goal. 🏔🎉
Very excited to announce @reverielabs $25M Series A round, led by Ridgeback Capital! I'm in awe of our team and what they've accomplished so far. Now back to executing on our mission of bringing life saving medicines to patients, ASAP! https://t.co/IvoKN7rmSU
0
1
18
Congrats to @ReverieLabs on the new financing! I’m very proud that we @Neo have backed you from the beginning. @JonahCallinBack and @GuptaAnkitV, here’s to the next level! 🚀
endpoints.news
Jonah Kallenbach spent the summer before his senior year with Anton, the hulking fluorescent supercomputer housed in the midtown Manhattan offices of hedge fund D.E. Shaw. Armed with 512 processors...
0
3
21
Congrats to @reverielabs (and founders @JonahCallinBack and @GuptaAnkitV) on raising $25M to further their goal of contributing exquisitely specific kinase inhibitors to humanity's armamentarium for fighting disease... https://t.co/kg9WePPTEj
endpoints.news
Jonah Kallenbach spent the summer before his senior year with Anton, the hulking fluorescent supercomputer housed in the midtown Manhattan offices of hedge fund D.E. Shaw. Armed with 512 processors...
2
3
28